CDA-HFD-fed mice developed significant pericellular fibrosis with HSC activation as evaluated by Sirius red and α-smooth muscle actin (α-SMA) staining, whereas treatment with imeglimin improved CDA-HFD feeding-induced hepatic fibrosis development (Figure 4A–C). The gene discussed is ACTA1; the disease is Hepatic fibrosis.